Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

I turned 50 during the pandemic and, like most people, I put off all nonessential health care, including my shingles vaccine. Big mistake. When the telltale red bumps of shingles cropped up on my face ...

Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing ...